Teste para aumentar a frequência da FEP
Incentivos financeiros para aumentar a frequência ao tratamento no primeiro episódio psicótico: um estudo piloto adaptativo não randomizado
Individuals with first-episode psychosis (FEP) are at high-risk for several poor functional and clinical outcomes, including suicide. Coordinated Specialty Care (CSC) is a multidisciplinary, team-based intervention known to improve such outcomes, including suicide risk. However, 30-50% of patients disengage from CSC, thereby limiting its impact. This pilot study will develop and test feasibility of a behavioral change program that uses moderate financial incentives to encourage treatment engagement in 2 CSC programs. A single-arm of 80 patient-participants at these two clinics will be recruited to assess feasibility and acceptability from patient perspectives. Additionally,15 clinicians at these two clinics will be recruited to assess feasibility and acceptability from clinician perspectives, and 50 clinicians from peer clinics not involved in the intervention will be recruited to assess scalability of the intervention. The trial will feature an three-month period for recruitment and baseline data collection and will subsequently feature three intervention periods (3 months each) where modifications to the interventions will be tested (each informed by the feasibility and acceptability findings of the prior period) with the aim of sequentially improving it.
Visão geral do estudo
Status
Status
Condições
Condições
Intervenção / Tratamento
Intervenção / Tratamento
Tipo de estudo
Tipo de estudo
Inscrição (Estimado)
Inscrição
Estágio
Estágio
- Fase inicial 1
Contactos e Locais
Locais de estudo
-
-
North Carolina
-
Raleigh, North Carolina, Estados Unidos, 27608
- University of North Carolina at Chapel Hill (ENCOMPASS Program)
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, Estados Unidos, 19123
- PEACE Program, Horizon House, Inc.
-
Philadephia, Pennsylvania, Estados Unidos, 19104
- University of Pennsylvania
-
-
Critérios de participação
Critérios de elegibilidade
Critérios de elegibilidade
Idades elegíveis para estudo
Aceita Voluntários Saudáveis
Gêneros Elegíveis para o Estudo
Descrição
Inclusion Criteria:
- For all participants, age ≥ 18 years old.
- For intervention trial and patient feasibility and acceptability measurement: Patients with first-episode psychosis, enrolled in Coordinated Specialty Care at the Psychosis Education, Assessment, Care and Empowerment (PEACE) clinic and Psychosis Evaluation and Recovery Center (PERC).
- For clinician feasibility and acceptability measurement at intervention sites: Clinicians working at PEACE and PERC where the intervention will be piloted.
- For clinician implementation facilitator and barrier assessment at other Connection LHS sites to assess for scalability: Clinicians in Connection LHS who work at sites other than PEACE and PERC.Participants must sign the informed consent form
Exclusion Criteria:
- For intervention trial and patient feasibility and acceptability measurement: Expectation of leaving coordinated specialty care programing within 6 months (which will exclude all of the PI's patient panel) and/or intellectual disability of sufficient degree that the patient's primary psychiatrist expects to compromise capacity to consent to this research and/or psychosis secondary to another medical condition (which may not share the same motivational features that are otherwise understood about the primary psychiatric conditions with psychosis).
- For clinician feasibility and acceptability measurement at intervention sites: Study investigators who work at these clinics will be excluded from participation in the feasibility and acceptability study component given their role in the trial planning and execution.
- For clinician implementation facilitator and barrier assessment at other Connection LHS sites to assess for scalability: none.
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Tratamento
- Alocação: Não randomizado
- Modelo Intervencional: Atribuição de grupo único
- Mascaramento: Nenhum (rótulo aberto)
O que o estudo está medindo?
Medidas de resultados primários
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Acceptability of intervention measure (AIM)
Prazo: Change at 8 months
|
The AIM is a 4-item scale measuring acceptability. Each item is scored 1-5 with 5 indicating greater acceptability. Minimum score is 4; maximum is 20. |
Change at 8 months
|
|
Acceptability of intervention measure (AIM)
Prazo: Change at 6 months
|
The AIM is a 4-item scale measuring acceptability. Each item is scored 1-5 with 5 indicating greater acceptability. Minimum score is 4; maximum is 20. |
Change at 6 months
|
|
Acceptability of intervention measure (AIM)
Prazo: Change at 4 months
|
The AIM is a 4-item scale measuring acceptability. Each item is scored 1-5 with 5 indicating greater acceptability. Minimum score is 4; maximum is 20. |
Change at 4 months
|
|
Feasibility of intervention measure (FIM)
Prazo: Change at 8 months
|
The FIM is a 4-item scale measuring feasibility. Each item is scored 1-5 with 5 indicating greater feasibility. Minimum score is 4; maximum is 20. |
Change at 8 months
|
|
Feasibility of intervention measure (FIM)
Prazo: Change at 6 months
|
The FIM is a 4-item scale measuring feasibility. Each item is scored 1-5 with 5 indicating greater feasibility. Minimum score is 4; maximum is 20. |
Change at 6 months
|
|
Feasibility of intervention measure (FIM)
Prazo: Change at 4 months
|
The FIM is a 4-item scale measuring feasibility. Each item is scored 1-5 with 5 indicating greater feasibility. Minimum score is 4; maximum is 20. |
Change at 4 months
|
Medidas de resultados secundários
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Implementation Survey Response
Prazo: Change at 8 months
|
Implementation survey. Results will be used to optimize intervention from implementation perspective. |
Change at 8 months
|
|
Implementation Survey Response
Prazo: Change at 6 months
|
Implementation survey. Results will be used to optimize intervention from implementation perspective. |
Change at 6 months
|
|
Implementation Survey Response
Prazo: Change at 4 months
|
Implementation survey. Results will be used to optimize intervention from implementation perspective. |
Change at 4 months
|
|
Motivation Survey Response
Prazo: Change at 8 months
|
Motivation survey. Results will be used to optimize intervention from motivation perspective. |
Change at 8 months
|
|
Motivation Survey Response
Prazo: Change at 6 months
|
Motivation survey. Results will be used to optimize intervention from motivation perspective. |
Change at 6 months
|
|
Motivation Survey Response
Prazo: Change at 4 months
|
Motivation survey. Results will be used to optimize intervention from motivation perspective. |
Change at 4 months
|
|
Ethical Concern Survey Response
Prazo: Change at 8 months
|
Ethical concern survey. Results will be used to optimize intervention from ethical acceptability perspective. |
Change at 8 months
|
|
Ethical Concern Survey Response
Prazo: Change at 6 months
|
Ethical concern survey. Results will be used to optimize intervention from ethical acceptability perspective. |
Change at 6 months
|
|
Ethical Concern Survey Response
Prazo: Change at 4 months
|
Ethical concern survey. Results will be used to optimize intervention from ethical acceptability perspective. |
Change at 4 months
|
Outras medidas de resultado
Outras medidas de resultado
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
attrition
Prazo: Change at 8 months
|
rate of attrition |
Change at 8 months
|
|
attrition
Prazo: Change at 6 months
|
rate of attrition |
Change at 6 months
|
|
attrition
Prazo: Change at 4 months
|
rate of attrition |
Change at 4 months
|
|
psychotic symptomology
Prazo: Change at 8 months
|
Compass-10. The Compass-10 is a self-report scale that measures multiple symptoms associated with psychosis, including mood symptoms. It consists of 10-items, each scored 0-6 with a minimum score of 0 and a maximum of 60. A higher score indicates greater symptomology. |
Change at 8 months
|
|
psychotic symptomology
Prazo: Change at 6 months
|
Compass-10. The Compass-10 is a self-report scale that measures multiple symptoms associated with psychosis, including mood symptoms. It consists of 10-items, each scored 0-6 with a minimum score of 0 and a maximum of 60. A higher score indicates greater symptomology. |
Change at 6 months
|
|
psychotic symptomology
Prazo: Change at 4 months
|
Compass-10. The Compass-10 is a self-report scale that measures multiple symptoms associated with psychosis, including mood symptoms. It consists of 10-items, each scored 0-6 with a minimum score of 0 and a maximum of 60. A higher score indicates greater symptomology. |
Change at 4 months
|
|
psychotic symptomology
Prazo: Change at 8 months
|
modified-Colorado Symptom Index. The modified-Colorado Symptom Index is a 14-item, clinician-rated scale with items ranked 0-4. Total minimum score = 0. Total maximum score = 56. A higher score indicates greater symptomology. |
Change at 8 months
|
|
psychotic symptomology
Prazo: Change at 6 months
|
modified-Colorado Symptom Index. The modified-Colorado Symptom Index is a 14-item, clinician-rated scale with items ranked 0-4. Total minimum score = 0. Total maximum score = 56. A higher score indicates greater symptomology. |
Change at 6 months
|
|
psychotic symptomology
Prazo: Change at 4 months
|
modified-Colorado Symptom Index. The modified-Colorado Symptom Index is a 14-item, clinician-rated scale with items ranked 0-4. Total minimum score = 0. Total maximum score = 56. A higher score indicates greater symptomology. |
Change at 4 months
|
|
depression
Prazo: Change at 8 months
|
abbreviated version of the Beck Depression Inventory-II (BDI-II) that has been previously validated (scale, min=0, max=21, higher mean score indicates more severe depressive symptomology) |
Change at 8 months
|
|
depression
Prazo: Change at 6 months
|
abbreviated version of the Beck Depression Inventory-II (BDI-II) that has been previously validated (scale, min=0, max=21, higher mean score indicates more severe depressive symptomology) |
Change at 6 months
|
|
depression
Prazo: Change at 4 months
|
abbreviated version of the Beck Depression Inventory-II (BDI-II) that has been previously validated (scale, min=0, max=21, higher mean score indicates more severe depressive symptomology) |
Change at 4 months
|
|
quality of life
Prazo: Change at 8 months
|
4-item version of the Lehman Quality of Life Scale (min = 4, max =28, higher score is improved quality of life) |
Change at 8 months
|
|
quality of life
Prazo: Change at 6 months
|
4-item version of the Lehman Quality of Life Scale (min = 4, max =28, higher score is improved quality of life) |
Change at 6 months
|
|
quality of life
Prazo: Change at 4 months
|
4-item version of the Lehman Quality of Life Scale (min = 4, max =28, higher score is improved quality of life) |
Change at 4 months
|
|
recovery
Prazo: Change at 8 months
|
5-item version of the Questionnaire about the Process of Recovery (scale, min=5, max=25, higher mean indicates more perceived recovery) |
Change at 8 months
|
|
recovery
Prazo: Change at 6 months
|
5-item version of the Questionnaire about the Process of Recovery (scale, min=5, max=25, higher mean indicates more perceived recovery) |
Change at 6 months
|
|
recovery
Prazo: Change at 4 months
|
5-item version of the Questionnaire about the Process of Recovery (scale, min=5, max=25, higher mean indicates more perceived recovery) |
Change at 4 months
|
|
treatment motivation (intrinsic versus extrinsic)
Prazo: Change at 8 months
|
Treatment Motivation Questionnaire-Revised (TMQ-R). The Treatment Motivation Questionnaire-Revised is a 25-item self-assessment survey that assesses several elements of treatment motivation, each ranked 1-5. It is not a single scale that results in an overall score. Some items suggest greatest motivation at a 5 and least at a 1, but others suggest greatest motivation at a 1 and least at a 5. |
Change at 8 months
|
|
treatment motivation (intrinsic versus extrinsic)
Prazo: Change at 6 months
|
Treatment Motivation Questionnaire-Revised (TMQ-R). The Treatment Motivation Questionnaire-Revised is a 25-item self-assessment survey that assesses several elements of treatment motivation, each ranked 1-5. It is not a single scale that results in an overall score. Some items suggest greatest motivation at a 5 and least at a 1, but others suggest greatest motivation at a 1 and least at a 5. |
Change at 6 months
|
|
treatment motivation (intrinsic versus extrinsic)
Prazo: Change at 4 months
|
Treatment Motivation Questionnaire-Revised (TMQ-R). The Treatment Motivation Questionnaire-Revised is a 25-item self-assessment survey that assesses several elements of treatment motivation, each ranked 1-5. It is not a single scale that results in an overall score. Some items suggest greatest motivation at a 5 and least at a 1, but others suggest greatest motivation at a 1 and least at a 5. |
Change at 4 months
|
|
Perceived coercion
Prazo: Change at 8 months
|
Modified version of the MacArthur Admission Experience Survey (AES). The MacArthur AES was developed as a self-assessment for assessing coercion and pressure during inpatient admission. It was previously modified for assisted outpatient treatment. We have modified it further to a 13-item scale for outpatient treatment generally. Each item is assessed as true or false, where true suggests great perception of pressure or coercion on some items, but less on others. |
Change at 8 months
|
|
Perceived coercion
Prazo: Change at 6 months
|
Modified version of the MacArthur Admission Experience Survey (AES). The MacArthur AES was developed as a self-assessment for assessing coercion and pressure during inpatient admission. It was previously modified for assisted outpatient treatment. We have modified it further to a 13-item scale for outpatient treatment generally. Each item is assessed as true or false, where true suggests great perception of pressure or coercion on some items, but less on others. |
Change at 6 months
|
|
Perceived coercion
Prazo: Change at 4 months
|
Modified version of the MacArthur Admission Experience Survey (AES). The MacArthur AES was developed as a self-assessment for assessing coercion and pressure during inpatient admission. It was previously modified for assisted outpatient treatment. We have modified it further to a 13-item scale for outpatient treatment generally. Each item is assessed as true or false, where true suggests great perception of pressure or coercion on some items, but less on others. |
Change at 4 months
|
|
attendance rate
Prazo: Change over 8 months
|
number of appointments attended in a given period divided by number of appointments scheduled |
Change over 8 months
|
|
attendance rate
Prazo: Change at 6 months
|
number of appointments attended in a given period divided by number of appointments scheduled |
Change at 6 months
|
|
attendance rate
Prazo: Change at 4 months
|
number of appointments attended in a given period divided by number of appointments scheduled |
Change at 4 months
|
Colaboradores e Investigadores
Patrocinador
Patrocinador
Colaboradores
Colaboradores
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Real)
Início do estudo
Conclusão Primária (Real)
Conclusão Primária
Conclusão do estudo (Estimado)
Conclusão do estudo
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Primeira postagem
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última Atualização Postada
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Última verificação
Mais Informações
Termos relacionados a este estudo
Outros números de identificação do estudo
Outros números de identificação do estudo
- 2023-03
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .